Aenova, one of the world's leading Contract Development and Manufacturing Organizations (CDMO) expands its offering for the development and manufacturing of high-potent active pharmaceutical ingredien ...
After a successful regulatory approvals process, the takeover of the pharma contract development and manufacturing organization Aenova by Kühne Holding AG was closed on August 29, 2024. The previous o ...
Aenova, one of the world's leading CDMOs (Contract Development and Manufacturing Organizations) for the pharmaceutical and healthcare industries, is implementing a new gummy line at its site in Cornu, ...
In recent years, the market demand for user-friendly injectable delivery systems has increased.
The development of Prefilled Syringes (PFS) has piqued substantial interest in the industry, primarily ...
Starnberg, 08 July 2024 - The Aenova Group has published its annual report for 2023, which reflects the most successful business year in the history of the Aenova Group. The financial results are very ...
Low aqueous drug solubility in pharmaceutical development is a recurring issue. The softgel capsule offers many possibilities in the development of new drugs, especially when it comes to solubility an ...
Aenova has once again achieved silver status in the latest EcoVadis sustainability rating. The rating documents the sustainability status of the Aenova Group in the categories "Environment", "Labor an ...
Kühne Holding AG has entered into a definitive agreement to acquire pharma contract development and manufacturing organization Aenova Group from leading international investment firm BC Partners. As p ...
Dr Anne-Sophie Bonte has been appointed as the new Chief Quality Officer (CQO) at contract developer and manufacturer Aenova, with effect from March 01, 2024. She is also a member of the Executive Lea ...
Aenova has achieved the best result in the generics sector in a study on the innovative strength of German companies, making it the number one company in Germany. The study was conducted by the renown ...